BIO Calls For Journal Publication Of COVID-19 Trial Data, Independent FDA

 
• By Brenda Sandburg

In an open letter to the biopharmaceutical industry, BIO lays out principles for conducting COVID-19 clinical trials and disclosing and using the data. Senator Durbin asks eight vaccine makers backed by Operation Warp Speed how they will withstand political pressure to speed up the approval process.

Reading email document text file online on computer laptop or send electronic digital mail letter content on pc vector flat cartoon illustration, concept of newsletter correspondence modern design
BIO's open letter to industry sets principles for conducting and reviewing COVID-19 clinical trial data • Source: Shutterstock

More from Vaccines

More from Pink Sheet